ABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Langerhans Cell Sarcoma/diagnosis , Langerhans Cell Sarcoma/drug therapy , L-Lactate Dehydrogenase/blood , Neoplasm Recurrence, Local , Leukemia , Histiocytosis, Langerhans-Cell , Histiocytes/cytology , Mutation , Hematopoietic Stem Cell TransplantationABSTRACT
BACKGROUND: Acute T-cell leukemia lymphoma (ATLL) tumor cells generally express CD2/CD3/CD5, but lack CD7. These T cells are usually CD4+CD8- and strongly express CD25, although some variability in this basic pattern may be found. Here we report a case with a very unusual CD1a positive phenotype. METHODS: Samples from peripheral blood, bone marrow aspirate, lymph node, and cerebrospinal fluid obtained from a 45-year-old male patient with a T-cell lymphoproliferative disorder were immunophenotyped by multiparametric flow cytometry. Analysis of HTLV-I genome integration in tumoral cells was performed by PCR. RESULTS: Neoplastic T cells were cCD3, CD2/CD5/CD30/CD25, and CD1a positive, but CD3/CD7/CD4/CD8/CD34/CD10/TdT negative. Serology and integration of HTLV-I were positive. CONCLUSION: To the best of our knowledge, CD1a expression has not been previously described in this entity. Its detection raised the differential diagnosis with acute T lymphoblastic leukemia. The rest of the phenotypic markers, the morphology of the neoplastic cells, and the demonstration of HTLV-I genome integration provided the final diagnosis.
Subject(s)
Antigens, CD1/analysis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Flow Cytometry , Humans , Immunophenotyping , Male , Middle Aged , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/virologyABSTRACT
Background: Acute T-cell leukemia lymphoma (ATLL) tumor cells generally express CD2/CD3/CD5, but lack CD7. These T cells are usually CD4+CD8- and strongly express CD25, although some variability in this basic pattern may be found. Here we report a case with a very unusual CD1a positive phenotype. Methods: Samples from peripheral blood, bone marrow aspirate, lymph node and CSF obtained from a 45 year old male patient with a T-cell lymphoproliferative disorder were immunophenotyped by multiparametric flow cytometry Analysis of HTLV-I genome integration in tumoral cells was performed by PCR. Results: Neoplastic T cells were cCD3, CD2/CD5/CD30/CD25 and CD1a positive, but CD3/CD7/CD4/CD8/CD34/CD10/TdT negative. Serology and integration of HTLV-I were positive. Conclusion: To the best of our knowledge CD1a expression has not been previously described in this entity. Its detection raised the differential diagnosis with acute T lymphoblastic leukemia. The rest of the phenotypic markers, the morphology of the neoplastic cells, and the demonstration of HTLV-I genome integration provided the final diagnosis. © 2013 Clinical Cytometry Society.
